@drtester

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

, , , , , , , , , , , , , , , , , , , , , , , , , and . The Lancet Oncology, 9 (2): 105–116 (2008)

Links and resources

Tags